The rise of AI and synthetic biology has made deadly diseases look like a ‘low-risk, high-reward’ option for would-be ...

By looking at how sci-fi movies used emergent technologies to discuss pressing issues, we get a clearer picture of the 1990s ...

On March 25, 2026 the Jeffrey Modell Foundation (JMF) will host Donald B. Kohn, MD, a Distinguished Professor at the ...

From Frank's RedHot to Hellmann's, AI already changed what we taste, but greater success in test kitchens will be harder for artificial intelligence to create.

The purpose of this survey was to combine qualitative and quantitative insights to understand the current oncology landscape.

Oliver van Veen, the chief executive officer (CEO) of Vannin Healthcare, says the federal government should adopt a ...

From antibiotic resistance to emerging viral threats, the global demand for new medicines is intensifying, yet traditional drug discovery pipelines remain slow and expensive. A new scientific review ...

Detailed price information for Bionano Genomics Inc (BNGO-Q) from The Globe and Mail including charting and trades.

“The medical city represents a qualitative move towards advanced medical care, multi-disciplinary scientific research, and ...

DUBAI – In a solid executive action that is in accordance with the UAE's National Strategy for Artificial Intelligence 2031, ...

Brooks Consulting's Chuck Brooks, a GovCon Expert, explains how AI and quantum technologies are becoming mission-critical ...

Pfizer, Eli Lilly, Novartis, Bristol Myers Squibb and AstraZeneca are all ramping up the use of AI, but drug discovery is not the primary success story—yet.